• MSKCC’s James J. Mezhir, MD recently presented results of a single-center study of 291 patients that was conducted to determine the clinical, pathologic and treatment-related variables associated with survival in patients with positive cytology.
• Dr. Howard I. Amols, chief of clinical physics at MSKCC, was quoted in a New York Times article about enhanced safety measures in administering medical radiation.
• CNNMoney reported that MSKCC Neurosurgeon-Scientist Eric C. Holland, MD, PhD is set to join Health Enhancement Products Scientific Advisory Board effective immediately.

Filed under: MSKCC in the News